Exchange: NYSE·Updated 07:50 PM EDT

HNGE News

News
all
press releases
Hinge Health to announce third quarter 2026 financial results on November 2, 2026
Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2026, after the U.S. financial markets close on Monday, November 2, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30...
Business Wire
Hinge Health to announce third quarter 2026 financial results on November 2, 2026
Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2026, after the U.S. financial markets close on Monday, November 2, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30...
Business Wire
More News
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.
Zacks
Hinge Health Director Kristina Leslie Sells 1,200 Shares for $105,876
Key PointsThe transaction reduced her direct equity position by 4% while maintaining a multi-million dollar stake in the company...
Nasdaq News: Markets
Hinge Health Inc. (HNGE) Up 13.7% Since Last Earnings Report: Can It Continue?
Hinge Health Inc. (HNGE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?
Hinge Health's nearly 90% YTD surge is backed by 53% revenue growth, wider margins and expansion into migraine and GI care, but execution risks remain.
Zacks
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.
Zacks
Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?
HNGE's rapid revenue growth, widening margins and higher 2026 outlook strengthen its case, but expansion raises execution risks.
Zacks
Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity
HNGE's $105 million Cylinder deal opens a $135 billion GI care market, adding nearly 100 clients and about 2 million lives.
Zacks
HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum
Hinge Health 64.6% three-month rally is backed by surging revenues, wider margins and a raised 2026 outlook, but execution expectations are rising.
Zacks
Is the Options Market Predicting a Spike in Hinge Health Stock?
Investors need to pay close attention to HNGE stock based on the movements in the options market lately.
Zacks

Advertisement|Remove ads.